Napredna pretraga

Pregled bibliografske jedinice broj: 539701

Perforin expression after acute myocardial infarction : a pilot study


Ružić, Alen; Miletić, Bojan; Balen, Sanja; Peršić, Viktor; Travica Samsa, Dijana; Rakić, Marijana; Pehar Pejčinović, Vesna; Hajdin, Jelena; Včev, Aleksandar; Laškarin, Gordana
Perforin expression after acute myocardial infarction : a pilot study // Collegium Antropologicum, 35 (2011), 1; 161-166 (međunarodna recenzija, članak, znanstveni)


Naslov
Perforin expression after acute myocardial infarction : a pilot study

Autori
Ružić, Alen ; Miletić, Bojan ; Balen, Sanja ; Peršić, Viktor ; Travica Samsa, Dijana ; Rakić, Marijana ; Pehar Pejčinović, Vesna ; Hajdin, Jelena ; Včev, Aleksandar ; Laškarin, Gordana

Izvornik
Collegium Antropologicum (0350-6134) 35 (2011), 1; 161-166

Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni

Ključne riječi
Atherosclerosis; cardiovascular disease; myocardial infarction; perforin; percutaneous coronary intervention

Sažetak
Perforin is an important mediator of inflammatory reactions. It is a quick-action cytotoxic mediator accumulated in the cytoplasmic granules of effector immunity cells (T lymphocytes, NK and NKT cells) which provide death signal in infected or transformed cells. Perforin-positive cells were previously detected in myocardial tissue during Trypanosoma cruzi infection and viral myocarditis while its role in chronic and progressive cardiovascular inflammatory disease such as atherosclerosis is almost completely unexplored. The perforin activity is also untested during acute coronary events that represent unexpected atherosclerotic complications due to the inflammatory destabilisation and atherosclerotic plaque rupture. The aim of this study was to investigate the presence of perforin, an important immunological inflammatory molecule in peripheral blood lymphocytes during the early period after acute myocardial infarction. We analyzed three subject groups: women with ST-segment elevation acute myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI), conservatively treated women with acute myocardial infarction without ST-segment elevation (NSTEMI) and a control group of healthy volunteers. The STEMI and NSTEMI groups did not basically differ in medication neither in levels of routine laboratory tests, while troponin I were significantly higher in the STEMI group. In the study, we detected an early decrease of perforin-positive lymphocytes in STEMI patients that were in contrast with their persisting elevation among NSTEMI patients. Despite greater myocardial necrosis in the STEMI group, results of this pilot-study indicated the prolonged perforin-mediated inflammatory response in patients with NSTEMI. This perforin down-regulation that follows the coronary interventional reperfusion in STEMI emphasized the possible anti-inflammatory role of primary PCI among patients with acute myocardial infarction. Given that the issue of routine primary PCI in NSTEMI is nowadays highly topical, the results we expect in the wake of this pilot study could demonstrate a significant impact on clinical practice. Further research is needed to confirm these results, compare the perforin-mediated activity to other inflammatory mediators in acute coronary events and to examine their impact on the long-term outcome.

Izvorni jezik
Engleski

Znanstvena područja
Temeljne medicinske znanosti, Kliničke medicinske znanosti



POVEZANOST RADA


Projekt / tema
062-0620402-0377 - Imunoregulacijske funkcije antigen predočnih stanica tijekom rane trudnoće (Gordana Laškarin, )
239823

Ustanove
Medicinski fakultet, Rijeka

Časopis indeksira:


  • Current Contents Connect (CCC)
  • Web of Science Core Collection (WoSCC)
    • Social Science Citation Index (SSCI)
    • SCI-EXP, SSCI i/ili A&HCI
  • Scopus
  • MEDLINE